Cargando…

Component with abundant immune‐related cells in combined hepatocellular cholangiocarcinoma identified by cluster analysis

Combined hepatocellular cholangiocarcinoma (cHCC‐CCA) is a heterogeneous tumor sharing histological features with hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (iCCA). The tumor immune microenvironment (TIME) of cHCC‐CCA is unclear. We compared the TIME of cHCC‐CCA with that of...

Descripción completa

Detalles Bibliográficos
Autores principales: Yagi, Naoki, Suzuki, Toshihiro, Mizuno, Shoichi, Kojima, Motohiro, Kudo, Masashi, Sugimoto, Motokazu, Kobayashi, Shin, Gotohda, Naoto, Ishii, Genichiro, Nakatsura, Tetsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128159/
https://www.ncbi.nlm.nih.gov/pubmed/35226764
http://dx.doi.org/10.1111/cas.15313
_version_ 1784712503904698368
author Yagi, Naoki
Suzuki, Toshihiro
Mizuno, Shoichi
Kojima, Motohiro
Kudo, Masashi
Sugimoto, Motokazu
Kobayashi, Shin
Gotohda, Naoto
Ishii, Genichiro
Nakatsura, Tetsuya
author_facet Yagi, Naoki
Suzuki, Toshihiro
Mizuno, Shoichi
Kojima, Motohiro
Kudo, Masashi
Sugimoto, Motokazu
Kobayashi, Shin
Gotohda, Naoto
Ishii, Genichiro
Nakatsura, Tetsuya
author_sort Yagi, Naoki
collection PubMed
description Combined hepatocellular cholangiocarcinoma (cHCC‐CCA) is a heterogeneous tumor sharing histological features with hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (iCCA). The tumor immune microenvironment (TIME) of cHCC‐CCA is unclear. We compared the TIME of cHCC‐CCA with that of HCC and iCCA. Twenty‐three patients with cHCC‐CCA after hepatectomy were evaluated in this study. Twenty‐three patients with iCCA and HCC were also included. iCCA was matched for size, and HCC was matched for size and hepatitis virus infection with cHCC‐CCA. Immune‐related cells among the iCCA‐component of cHCC‐CCA (C‐com), HCC‐component of cHCC‐CCA (H‐com), iCCA, and HCC were assessed using multiplex fluorescence immunohistochemistry. Among C‐com, H‐com, iCCA, and HCC, multiple comparisons and cluster analysis with k‐nearest neighbor algorithms were performed using immunological variables. Although HCC had more T lymphocytes and lower PD‐L1 expression than iCCA (P < 0.05), there were no significant differences in immunological variables between C‐com and H‐com. C‐com tended to have more T lymphocytes than iCCA (P = 0.09), and C‐com and H‐com had fewer macrophages than HCC (P < 0.05). In cluster analysis, all samples were classified into two clusters: one cluster had more immune‐related cells than the other, and 12 of 23 H‐com and eight of 23 C‐com were identified in this cluster. The TIME of C‐com and H‐com may be similar, and some immunological features in these components were different from those in HCC and some iCCA. Cluster analysis identified components with abundant immune‐related cells in cHCC‐iCCA.
format Online
Article
Text
id pubmed-9128159
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-91281592022-05-25 Component with abundant immune‐related cells in combined hepatocellular cholangiocarcinoma identified by cluster analysis Yagi, Naoki Suzuki, Toshihiro Mizuno, Shoichi Kojima, Motohiro Kudo, Masashi Sugimoto, Motokazu Kobayashi, Shin Gotohda, Naoto Ishii, Genichiro Nakatsura, Tetsuya Cancer Sci ORIGINAL ARTICLES Combined hepatocellular cholangiocarcinoma (cHCC‐CCA) is a heterogeneous tumor sharing histological features with hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (iCCA). The tumor immune microenvironment (TIME) of cHCC‐CCA is unclear. We compared the TIME of cHCC‐CCA with that of HCC and iCCA. Twenty‐three patients with cHCC‐CCA after hepatectomy were evaluated in this study. Twenty‐three patients with iCCA and HCC were also included. iCCA was matched for size, and HCC was matched for size and hepatitis virus infection with cHCC‐CCA. Immune‐related cells among the iCCA‐component of cHCC‐CCA (C‐com), HCC‐component of cHCC‐CCA (H‐com), iCCA, and HCC were assessed using multiplex fluorescence immunohistochemistry. Among C‐com, H‐com, iCCA, and HCC, multiple comparisons and cluster analysis with k‐nearest neighbor algorithms were performed using immunological variables. Although HCC had more T lymphocytes and lower PD‐L1 expression than iCCA (P < 0.05), there were no significant differences in immunological variables between C‐com and H‐com. C‐com tended to have more T lymphocytes than iCCA (P = 0.09), and C‐com and H‐com had fewer macrophages than HCC (P < 0.05). In cluster analysis, all samples were classified into two clusters: one cluster had more immune‐related cells than the other, and 12 of 23 H‐com and eight of 23 C‐com were identified in this cluster. The TIME of C‐com and H‐com may be similar, and some immunological features in these components were different from those in HCC and some iCCA. Cluster analysis identified components with abundant immune‐related cells in cHCC‐iCCA. John Wiley and Sons Inc. 2022-03-17 2022-05 /pmc/articles/PMC9128159/ /pubmed/35226764 http://dx.doi.org/10.1111/cas.15313 Text en © 2022 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle ORIGINAL ARTICLES
Yagi, Naoki
Suzuki, Toshihiro
Mizuno, Shoichi
Kojima, Motohiro
Kudo, Masashi
Sugimoto, Motokazu
Kobayashi, Shin
Gotohda, Naoto
Ishii, Genichiro
Nakatsura, Tetsuya
Component with abundant immune‐related cells in combined hepatocellular cholangiocarcinoma identified by cluster analysis
title Component with abundant immune‐related cells in combined hepatocellular cholangiocarcinoma identified by cluster analysis
title_full Component with abundant immune‐related cells in combined hepatocellular cholangiocarcinoma identified by cluster analysis
title_fullStr Component with abundant immune‐related cells in combined hepatocellular cholangiocarcinoma identified by cluster analysis
title_full_unstemmed Component with abundant immune‐related cells in combined hepatocellular cholangiocarcinoma identified by cluster analysis
title_short Component with abundant immune‐related cells in combined hepatocellular cholangiocarcinoma identified by cluster analysis
title_sort component with abundant immune‐related cells in combined hepatocellular cholangiocarcinoma identified by cluster analysis
topic ORIGINAL ARTICLES
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128159/
https://www.ncbi.nlm.nih.gov/pubmed/35226764
http://dx.doi.org/10.1111/cas.15313
work_keys_str_mv AT yaginaoki componentwithabundantimmunerelatedcellsincombinedhepatocellularcholangiocarcinomaidentifiedbyclusteranalysis
AT suzukitoshihiro componentwithabundantimmunerelatedcellsincombinedhepatocellularcholangiocarcinomaidentifiedbyclusteranalysis
AT mizunoshoichi componentwithabundantimmunerelatedcellsincombinedhepatocellularcholangiocarcinomaidentifiedbyclusteranalysis
AT kojimamotohiro componentwithabundantimmunerelatedcellsincombinedhepatocellularcholangiocarcinomaidentifiedbyclusteranalysis
AT kudomasashi componentwithabundantimmunerelatedcellsincombinedhepatocellularcholangiocarcinomaidentifiedbyclusteranalysis
AT sugimotomotokazu componentwithabundantimmunerelatedcellsincombinedhepatocellularcholangiocarcinomaidentifiedbyclusteranalysis
AT kobayashishin componentwithabundantimmunerelatedcellsincombinedhepatocellularcholangiocarcinomaidentifiedbyclusteranalysis
AT gotohdanaoto componentwithabundantimmunerelatedcellsincombinedhepatocellularcholangiocarcinomaidentifiedbyclusteranalysis
AT ishiigenichiro componentwithabundantimmunerelatedcellsincombinedhepatocellularcholangiocarcinomaidentifiedbyclusteranalysis
AT nakatsuratetsuya componentwithabundantimmunerelatedcellsincombinedhepatocellularcholangiocarcinomaidentifiedbyclusteranalysis